BM4500 Lamin-A/C (LMNA) antibody

See related secondary antibodies

Search for all "Lamin-A/C (LMNA)"

0.1 mg / €350.00
Delivery Time: 2-3 working days

Quick Overview

Mouse anti Bovine, Canine, Human, Mouse, Rat Lamin-A/C (LMNA) 133A2

BM4500

More Views

  • BM4500
  • BM4500
  • BM4500

Product Description for Lamin-A/C (LMNA)

Mouse anti Bovine, Canine, Human, Mouse, Rat Lamin-A/C (LMNA) 133A2.
Presentation: Purified
Product is tested for Paraffin Sections, Frozen Sections, Immunocytochemistry/Immunofluorescence, Western blot / Immunoblot, Flow Cytometry.

Properties for Lamin-A/C (LMNA)

Product Category Antibodies
Quantity 0.1 mg
Synonyms 70 kDa Lamin, FocusOn028, FocusOn098, LMN1, LMNA, Lamin A, Lamin A + C, Lamin-A/C, NY-REN-32, NYREN32, Nuclear Envelope Marker, Renal carcinoma antigen NY-REN-32
Presentation Purified
Reactivity Bov, Can, Hu, Ms, Rt
Applications C, F, ICC/IF, P, WB
Clonality Monoclonal
Clone 133A2
Host Mouse
Isotype IgG3
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH

Datasheet Extract

Immunogen
Swiss Prot Num:
P02545
Immunogen:
Partially purified recombinant Human Lamin A.
Genename:
4000
Antibody type Ab
Application Immunoblotting: 1/100-1/1000.
Flow Cytometry:1/100-1/200. 
Immunocytochemistry: 1/100-1/200. 
Immunofluorescence: 1 µg/ml. 
Immunohistochemistry on Frozen Sections: 1/100-1/200 with avidin-biotinylated horseradish peroxidase complex (ABC) as detection reagent. 
Immunohistochemistry on Paraffin Sections: 1/2000-1/2500.
Background Nuclear lamins form a network of intermediate-type filaments at the nucleoplasmic site of the nuclear membrane. Two main subtypes of nuclear lamins can be distinguished, i.e. A-type lamins and B-type lamins. The A-type lamins comprise a set of three proteins arising from the same gene by alternative splicing, i.e. lamin A, lamin C and lamin Adel 10, while the B-type lamins include two proteins arising from two distinct genes, i.e. lamin B1 and lamin B2. Recent evidence has revealed that mutations in A-type lamins give rise to a range of rare but dominant genetic disorders, including Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy with conduction-system disease and Dunnigan-type familial partial lipodystrophy. In addition, the expression of A-type lamins coincides with cell differentiation and as A-type lamins specifically interact with chromatin, a role in the regulation of differential gene expression has been suggested for A-type lamins.
Concentration 1.0 mg/ml
Protocols Immunofluorescence protocol - Formaldehyde fixation
1. Collect cells from T.c.unit and remove media from petri dish using suction.
2. Wash with 1x PBS and remove.
3. Incubate cells in pre-warm (37°C) Para-Formaldehyde for 12 minutes at room temperature on an orbital shaker.
4. Remove PFA and incubate in 0.5% Triton X-IOO in 1x PBS for 5 minutes at room temperature.
5. Prepare blocking reagent, this is also the antibody diluent.
6. Wash cells 2x with 1x PBS at room temperature, for 4 minutes/wash on an orbital shaker.
7. Block with 1 % NCS and 1x PBS for 30 minutes at room temperature.
8. Prepare primary antibodies (50μl/coverslip) and moist staining chambers.
9. Wash cells 2x with lx PBS at room temperature and air dry briefly.
10. Incubate with primary antibody for 1 hr at room temperature in the dark in staining chambers. During this time prepare the secondary antibody.
11. Wash cells 5x with 1x PBS (5 beaker changes/5 counts in each beaker)
12. Incubate with secondary antibody for 1 hour at room temperature in the dark in staining chambers.
13. Wash cells 5x with 1x PBS.
14. Mount in Dapi.

Solutions (prepare fresh the same day of staining).
1x Phosphate buffered saline.
Blocking reagent: 1% NCS in 1x PBS (use fresh l0x PBS).
Fixation solution: 3.5% Para-Formaldehyde.

1.75g PFA in 20 ml d.H20 plus 5 drops 1 M NaOH. Stir on a hot plate at 50-60°C until dissolved. Add 4 drops I N HCI and check pH indicator strip. pH should be 7.4. Complete volume with d.H20 to 25ml and add 25ml 2xPBS. Check pH before adding to cover slips.


Immunofluorescence protocol - Methanol/acetone fixation
1. Collect cells from T.C.unit and remove media from petri dish using suction.
2. Wash with 1x PBS and remove.
3. Fix cells with cold methanol: acetone 1: 1 for 10 minutes on ice.
4. Prepare blocking reagent, this is also the diluent for the antibodies.
5. Remove fixative and wash cells 3x with Ix PBS at RT, for 4 minutes/wash on orbital shaker.
6. Block with 1% NCS and Ix PBS for 30 minutes at RT.
7. Prepare primary antibodies (50μl/coverslip) and moist staining chambers.
8. Wash cells 2x with 1 x PBS at RT and air dry for approximately 7 minutes.
9. Incubate with primary antibody for 1 hr at RT in the dark in staining chambers. During this time prepare secondary antibody.
10. Wash cells 5x with 1x PBS (5 beaker changes/5 counts in each beaker)
11. Incubate with secondary antibody for 1 hr at R T in the dark in staining chambers.
12. Wash cells 5x with 1x PBS.
13. Mount in Dapi.

Solutions (prepare fresh the same day of staining)
1x Phosphate buffered saline.
Blocking reagent: 1% NCS in 1x PBS (use fresh 10x PBS).
Fixation solution: methanol:acetone 1: 1 ice cold.

Western Blotting Protocol
1. Transfer gel to PDVF or nitrocellulose membrane
2. Place membrane in plastic tray in blocking buffer for one hour with agitation
3. Rinse in wash buffer
4. Incubate in wash buffer plus primary antibody for one hour
5. Wash 6 X 5 minutes with wash buffer
6. Incubate in wash buffer plus secondary antibody for one hour
7. Wash 6X 5 minutes with wash buffer
8. Detect (e.g. ECL, Amersham according to manufacturers instructions)

Wash buffer
PBS + 0.1% Tween 20

Blocking buffer
Wash buffer + 5% dried milk powder
General Readings
  • Hozák P, Sasseville AM, Raymond Y, Cook PR. Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci. 1995 Feb;108 ( Pt 2):635-44. PubMed PMID: 7769007.
  • Machiels BM, Broers JL, Raymond Y, de Ley L, Kuijpers HJ, Caberg NE, et al. Abnormal A-type lamin organization in a human lung carcinoma cell line. Eur J Cell Biol. 1995 Aug;67(4):328-35. PubMed PMID: 8521872.
  • Broers JL, Machiels BM, Kuijpers HJ, Smedts F, van den Kieboom R, Raymond Y, et al. A- and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol. 1997 Jun;107(6):505-17. PubMed PMID: 9243284.
  • Pugh GE, Coates PJ, Lane EB, Raymond Y, Quinlan RA. Distinct nuclear assembly pathways for lamins A and C lead to their increase during quiescence in Swiss 3T3 cells. J Cell Sci. 1997 Oct;110 ( Pt 19):2483-93. PubMed PMID: 9410886.
  • Machiels BM, Ramaekers FC, Kuijpers HJ, Groenewoud JS, Oosterhuis JW, Looijenga LH. Nuclear lamin expression in normal testis and testicular germ cell tumours of adolescents and adults. J Pathol. 1997 Jun;182(2):197-204. PubMed PMID: 9274531.
  • Jansen MP, Machiels BM, Hopman AH, Broers JL, Bot FJ, Arends JW, et al. Comparison of A and B-type lamin expression in reactive lymph nodes and nodular sclerosing Hodgkin's disease. Histopathology. 1997 Oct;31(4):304-12. PubMed PMID: 9363444.
  • Neri LM, Raymond Y, Giordano A, Borgatti P, Marchisio M, Capitani S, et al. Spatial distribution of lamin A and B1 in the K562 cell nuclear matrix stabilized with metal ions. J Cell Biochem. 1999 Oct 1;75(1):36-45. PubMed PMID: 10462702.
  • Neri LM, Raymond Y, Giordano A, Capitani S, Martelli AM. Lamin A is part of the internal nucleoskeleton of human erythroleukemia cells. J Cell Physiol. 1999 Mar;178(3):284-95. PubMed PMID: 9989774.
  • Broers JL, Machiels BM, van Eys GJ, Kuijpers HJ, Manders EM, van Driel R, et al. Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J Cell Sci. 1999 Oct;112 ( Pt 20):3463-75. PubMed PMID: 10504295.
  • Broers JL, Bronnenberg NM, Kuijpers HJ, Schutte B, Hutchison CJ, Ramaekers FC. Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis. Eur J Cell Biol. 2002 Dec;81(12):677-91. PubMed PMID: 12553668.
  • De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003 Jun 27;300(5628):2055. Epub 2003 Apr 17. PubMed PMID: 12702809.
  • Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003 May 15;423(6937):293-8. Epub 2003 Apr 25. PubMed PMID: 12714972.
Storage Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Buffer System:
PBS containing 0.09% Sodium Azide as preservative
State:
Liquid purified Ig fraction
Purified
Specificity
Specificity:
The antibody recognizes an epitope located between residues 598-611 of Lamin A, therefore it reacts exclusively with Lamin A.
Species:
Human, Rat, Mouse, Bovine, Canine (Dog).
Gene ID 4000
FocusOn and Reviews
FocusOns:
Targets

Accessory Products

Proteins and/or Positive Controls

Positive controls for Lamin-A/C (LMNA) (3 products)

Catalog No. Species Pres. Purity   Source  
H00004000-T01

Lamin-A/C (LMNA) Lysate(Denatured)

Lamin-A/C (LMNA) Lysate(Denatured)
0.1 ml / €240.00
  Abnova Taiwan Corp.
NBL1-12564

Lamin A Lysate

Western Blot: Lamin A Lysate [NBL1-12564] - Western Blot experiments. 
Left-Control; Right -Over-expression Lysate for LMNA
0.1 mg / €370.00
  Novus Biologicals Inc.
NBL1-12565

Lamin A Lysate

Lamin A Lysate
0.1 mg / €370.00
  Novus Biologicals Inc.